Literature DB >> 21509187

GHRH and wound healing.

Hippokratis Kiaris1, Norman L Block, Athanasios G Papavassiliou, Andrew V Schally.   

Abstract

The principal action of growth hormone-releasing hormone (GHRH) is considered to be the stimulation of GH production and release in the pituitary.1 With the recent identification of wound-associated fibroblasts as a direct target of GHRH,2 this neuropeptide emerges as a rather pleiotropic hormone implicated in the regulation of various physiological and pathological processes and affecting diverse cell types.

Entities:  

Keywords:  GHRH; fibroblast; skin; wound healing; αSMA

Year:  2011        PMID： 21509187      PMCID： PMC3073279          DOI： 10.4161/cib.4.1.14002

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN： 1942-0889


  12 in total

Review 1.  Mechanisms of myofibroblast activity and phenotypic modulation.

Authors:  G Serini; G Gabbiani
Journal:  Exp Cell Res       Date:  1999-08-01       Impact factor: 3.905

2.  Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets.

Authors:  Barbara Ludwig; Christian G Ziegler; Andrew V Schally; Claudius Richter; Anja Steffen; Normund Jabs; Richard H Funk; Mathias D Brendel; Norman L Block; Monika Ehrhart-Bornstein; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

3.  Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation.

Authors:  C Moretti; A Bagnato; N Solan; G Frajese; K J Catt
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

4.  Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: evidence from studies on cell proliferation and c-myc proto-oncogene expression.

Authors:  H Kiaris; A V Schally; P Armatis
Journal:  Regul Pept       Date:  2001-01-12

Review 5.  IGF-1 signaling and aging.

Authors:  Martin Holzenberger; Laurent Kappeler; Carlos De Magalhaes Filho
Journal:  Exp Gerontol       Date:  2004 Nov-Dec       Impact factor: 4.032

6.  Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.

Authors:  Rosemeire M Kanashiro-Takeuchi; Konstantinos Tziomalos; Lauro M Takeuchi; Adriana V Treuer; Guillaume Lamirault; Raul Dulce; Michael Hurtado; Yun Song; Norman L Block; Ferenc Rick; Anna Klukovits; Qinghua Hu; Jozsef L Varga; Andrew V Schally; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-21       Impact factor: 11.205

7.  Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.

Authors:  Riccarda Granata; Letizia Trovato; Maria Pia Gallo; Silvia Destefanis; Fabio Settanni; Francesca Scarlatti; Alessia Brero; Roberta Ramella; Marco Volante; Jorgen Isgaard; Renzo Levi; Mauro Papotti; Giuseppe Alloatti; Ezio Ghigo
Journal:  Cardiovasc Res       Date:  2009-03-17       Impact factor: 10.787

Review 8.  Endocrine and antineoplastic actions of growth hormone-releasing hormone antagonists.

Authors:  Magdolna Kovács; Andrew V Schally; József L Varga; Márta Zarándi
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

Authors:  H Kiaris; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

10.  Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone.

Authors:  J Izdebski; J Pinski; J E Horvath; G Halmos; K Groot; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205
View more
  3 in total

1.  The PNEI holistic approach in coloproctology.

Authors:  M Pescatori; V Podzemny; L C Pescatori; M P Dore; G Bassotti
Journal:  Tech Coloproctol       Date:  2015-03-29       Impact factor: 3.781

2.  GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.

Authors:  Ferenc G Rick; Stephan Seitz; Andrew V Schally; Luca Szalontay; Awtar Krishan; Christian Datz; Andreas Stadlmayr; Stefan Buchholz; Norman L Block; Florian Hohla
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

Review 3.  The Local Neuropeptide System of Keratinocytes.

Authors:  Nicola Cirillo
Journal:  Biomedicines       Date:  2021-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.